Insider · CIK 0001752940

Kruse Bo

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001752940

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-31	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−31.4K sh	$12.07	−$379K	210,877
2024-05-31	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, CFO, SECRY & TREAS.	MExercise/Conversion	−31.4K sh	—	—	240,000
2024-05-31	Y-mAbs Therapeutics, Inc.M Exercise/Conversion	EVP, CFO, SECRY & TREAS.	MExercise/Conversion	+31.4K sh	$2.00	+$62.7K	242,248
2024-05-30	Y-mAbs Therapeutics, Inc.M Exercise/Conversion	EVP, CFO, SECRY & TREAS.	MExercise/Conversion	+28.6K sh	$2.00	+$57.3K	239,506
2024-05-30	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	EVP, CFO, SECRY & TREAS.	MExercise/Conversion	−28.6K sh	—	—	271,371
2024-05-30	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−28.6K sh	$12.03	−$344K	210,877
2024-01-18	Y-mAbs Therapeutics, Inc.A Award	EVP, CFO, SECRY & TREAS.	AAward	+18.1K sh	—	—	210,877
2024-01-18	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+109K sh	—	—	108,900
2023-01-17	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+70.1K sh	—	—	70,100
2023-01-17	Y-mAbs Therapeutics, Inc.A Award	EVP, CFO, SECRY & TREAS.	AAward	+11.7K sh	—	—	192,777
2022-04-26	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+75K sh	—	—	75,000
2022-02-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$7.85	−$31.4K	181,077
2022-02-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$7.97	−$31.9K	185,077
2022-01-24	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$9.84	−$39.4K	189,077
2022-01-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$17.12	−$68.5K	193,077
2021-12-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$16.36	−$65.4K	197,077
2021-12-14	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+85K sh	—	—	85,000
2021-12-06	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$16.35	−$65.4K	201,077
2021-11-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$18.09	−$72.4K	205,077
2021-11-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$27.54	−$110K	209,077
2021-10-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$25.94	−$104K	213,077
2021-10-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$28.78	−$115K	217,077
2021-09-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$30.82	−$123K	221,077
2021-09-07	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$32.03	−$128K	225,077
2021-08-23	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$28.60	−$114K	229,077
2021-08-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$33.72	−$135K	233,077
2021-07-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$34.50	−$138K	237,077
2021-07-06	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$34.15	−$137K	241,077
2021-06-22	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$36.17	−$145K	245,077
2021-06-04	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$33.48	−$134K	249,077
2021-05-24	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−4,000 sh	$35.61	−$142K	253,077
2020-12-15	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+72.4K sh	—	—	72,350
2020-05-14	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−28.2K sh	$36.03	−$1.02M	257,077
2020-05-14	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−37.8K sh	$36.03	−$1.36M	0
2020-05-13	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−19.2K sh	$37.88	−$728K	37,847
2020-05-13	Y-mAbs Therapeutics, Inc.S Sale	EVP, CFO, SECRY & TREAS.	SSale	−14.7K sh	$37.86	−$558K	285,276
2020-01-07	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+130K sh	—	—	130,000
2018-12-11	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	EVP, CFO, SECRY & TREAS.	AAward	+108K sh	—	—	107,500

Recent filings

Accepted (ET)
May 314
Kruse Bo0001104659-24-067356
SEC(opens sec.gov)
Jan 224
Kruse Bo0001415889-24-001644
SEC(opens sec.gov)
Jan 194
Kruse Bo0001104659-23-005026
SEC(opens sec.gov)
Apr 284
Kruse Bo0001104659-22-052513
SEC(opens sec.gov)
Feb 234
Kruse Bo0001104659-22-026182
SEC(opens sec.gov)
Feb 74
Kruse Bo0001104659-22-012870
SEC(opens sec.gov)
Jan 254
Kruse Bo0001104659-22-007441
SEC(opens sec.gov)
Jan 54
Kruse Bo0001104659-22-001565
SEC(opens sec.gov)
Dec 234
Kruse Bo0001104659-21-153184
SEC(opens sec.gov)
Dec 164
Kruse Bo0001104659-21-150626
SEC(opens sec.gov)
Dec 74
Kruse Bo0001104659-21-147273
SEC(opens sec.gov)
Nov 234
Kruse Bo0001104659-21-143090
SEC(opens sec.gov)
Nov 54
Kruse Bo0001104659-21-135122
SEC(opens sec.gov)

Companies

Y-mAbs Therapeutics, Inc.EVP, CFO, SECRY & TREAS.

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR

NEW YORK, NY, 10169